Yifang Biotechnology (Shanghai) Co., Ltd. is an entrepreneurial biomedical company established in 2013. It is committed to the research and development of new drugs in the fields of the tumor, tumor immunity, and metabolism. The company's product pipeline includes lung cancer, breast cancer, tumor immunity, and gout, etc. Small molecule drug candidates for targeted therapy in the field, and the company is also actively developing drugs for other tumor and immune tumor targets.

Pharmaceutical

InventisBio

Org chart

Teams

Leadership Team

Similar companies